Genes in panel
STRs in panel
Prev Next

Early onset or syndromic epilepsy

Gene: SEMA6B

Green List (high evidence)

SEMA6B (semaphorin 6B)
EnsemblGeneIds (GRCh38): ENSG00000167680
EnsemblGeneIds (GRCh37): ENSG00000167680
OMIM: 608873, Gene2Phenotype
SEMA6B is in 3 panels

6 reviews

Achchuthan Shanmugasundram (Genomics England Curator)

Comment on publications: PMID:35604360 reported new unrelated cases identified with heterozygous variants in SEMA6B. Out of 16 patients referred for ID clinic, 10 of them had epilepsy or myoclonus.

Functional studies of selected variants and shRNA knock down studies showed mislocalisation and abnormal protein function.
Created: 1 Mar 2023, 3:32 p.m. | Last Modified: 1 Mar 2023, 3:32 p.m.
Panel Version: 3.93
Comment on publications: PMID:35604360 reported new unrelated cases identified with heterozygous variants in SEMA6B. Out of 16 patients referred for ID clinic, 10 of them had epilepsy or myoclonus.

Functional studies of selected variants and shRNA knock down studies showed mislocalisation and abnormal protein function.
Created: 1 Mar 2023, 3:32 p.m. | Last Modified: 1 Mar 2023, 3:32 p.m.
Panel Version: 3.92
Comment on publications: PMID:35604360 reported new unrelated cases identified with heterozygous variants in SEMA6B. Out of 16 patients referred for ID clinic, 10 of them had epilepsy or myoclonus.

Functional studies of selected variants and shRNA knock down studies showed mislocalisation and abnormal protein function.
Created: 1 Mar 2023, 3:31 p.m. | Last Modified: 1 Mar 2023, 3:31 p.m.
Panel Version: 3.92

Sarah Leigh (Genomics England Curator)

The rating of this gene has been updated following NHS Genomic Medicine Service approval.
Created: 3 Mar 2022, 5:34 p.m. | Last Modified: 3 Mar 2022, 5:34 p.m.
Panel Version: 2.491

Helen Lord (Oxford Medical Genetics Laboratories)

I don't know

Hamanaka et al 2020 - Only seen in 4 individuals in 3 unrelated cases - all truncating de novo variants in the last exon - escape from NMD. They observed statistically significant enrichment of DNVs in NMD regions of 346 DEE trios. Although epilepsy is an initial feature, not sure there is enough evidence to make green?
Created: 31 Jan 2021, 8:32 p.m. | Last Modified: 31 Jan 2021, 8:32 p.m.
Panel Version: 2.281

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Publications

Arina Puzriakova (Genomics England Curator)

Comment on list classification: Changed rating from Green to Amber so that Green genes on this panel reflect the NHS signed-off version. This will be reviewed at the next GMS panel update (added 'for-review' tag).
Created: 20 Oct 2020, 2:11 p.m. | Last Modified: 20 Oct 2020, 2:11 p.m.
Panel Version: 2.186

Rebecca Foulger (Genomics England curator)

Comment on list classification: Gene was added to panel and rated Green by Zornitza Stark. Sufficient cases with seizure phenotype in PMID:32169168 plus mouse model. Not yet associated with a disorder in G2P but relevant OMIM phenotype. Therefore updated rating from Grey to Green.
Created: 1 Jun 2020, 4:09 p.m. | Last Modified: 1 Jun 2020, 4:10 p.m.
Panel Version: 2.80
Comment on mode of pathogenicity: The authors of PMID:32169168 suggest a dominant-negative or gain-of-function effect rather than haploinsufficiency.
Created: 1 Jun 2020, 4:08 p.m. | Last Modified: 1 Jun 2020, 4:08 p.m.
Panel Version: 2.79
PMID:32169168. In 4 unrelated patients (2 Japanese, 1 Israeli and 1 Malaysian) with progressive myoclonic epilepsy, Hamanaka et al. (2020) identified de novo heterozygous frameshift mutations in the last exon of the SEMA6B gene. Variants were predicted to result in truncated proteins. Truncating variants in this region of the gene were not observed in the gnomAD database, although truncating variants in other regions of the gene were observed in gnomAD. The authors postulated a dominant-negative or gain-of-function effect rather than haploinsufficiency. In an animal model, the authors found that zebrafish with truncating sema6b variants were more susceptible to seizures.
Created: 1 Jun 2020, 4:07 p.m. | Last Modified: 1 Jun 2020, 4:08 p.m.
Panel Version: 2.78

Zornitza Stark (Australian Genomics)

Green List (high evidence)

Five individuals from unrelated families reported with de novo variants in the last exon, escaping NMD.
Sources: Literature
Created: 20 Apr 2020, 2:40 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Progressive myoclonic epilepsy

Publications

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Green
Phenotypes
  • Epilepsy, progressive myoclonic, 11 OMIM:618876
OMIM
608873
Clinvar variants
Variants in SEMA6B
Penetrance
None
Publications
Mode of Pathogenicity
Other
Panels with this gene

History Filter Activity

1 Mar 2023, Gel status: 3

Set publications

Achchuthan Shanmugasundram (Genomics England Curator)

Publications for gene: SEMA6B were set to 32169168; 35604360

1 Mar 2023, Gel status: 3

Set publications

Achchuthan Shanmugasundram (Genomics England Curator)

Publications for gene: SEMA6B were set to 32169168; 35604360

1 Mar 2023, Gel status: 3

Set publications

Achchuthan Shanmugasundram (Genomics England Curator)

Publications for gene: SEMA6B were set to 32169168

3 Mar 2022, Gel status: 3

Removed Tag

Sarah Leigh (Genomics England Curator)

Tag for-review was removed from gene: SEMA6B.

3 Mar 2022, Gel status: 3

Added New Source, Status Update

Sarah Leigh (Genomics England Curator)

Source Expert Review Green was added to SEMA6B. Rating Changed from Amber List (moderate evidence) to Green List (high evidence)

1 Feb 2021, Gel status: 2

Set Phenotypes

Sarah Leigh (Genomics England Curator)

Phenotypes for gene: SEMA6B were changed from Epilepsy, progressive myoclonic, 11, 618876 to Epilepsy, progressive myoclonic, 11 OMIM:618876

20 Oct 2020, Gel status: 2

Entity classified by Genomics England curator

Arina Puzriakova (Genomics England Curator)

Gene: sema6b has been classified as Amber List (Moderate Evidence).

20 Oct 2020, Gel status: 3

Added Tag

Arina Puzriakova (Genomics England Curator)

Tag for-review tag was added to gene: SEMA6B.

1 Jun 2020, Gel status: 3

Entity classified by Genomics England curator

Rebecca Foulger (Genomics England curator)

Gene: sema6b has been classified as Green List (High Evidence).

1 Jun 2020, Gel status: 0

Set mode of pathogenicity

Rebecca Foulger (Genomics England curator)

Mode of pathogenicity for gene: SEMA6B was changed from None to Other

1 Jun 2020, Gel status: 0

Set Phenotypes

Rebecca Foulger (Genomics England curator)

Phenotypes for gene: SEMA6B were changed from Progressive myoclonic epilepsy to Epilepsy, progressive myoclonic, 11, 618876

20 Apr 2020, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Zornitza Stark (Australian Genomics)

gene: SEMA6B was added gene: SEMA6B was added to Genetic epilepsy syndromes. Sources: Literature Mode of inheritance for gene: SEMA6B was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: SEMA6B were set to 32169168 Phenotypes for gene: SEMA6B were set to Progressive myoclonic epilepsy Review for gene: SEMA6B was set to GREEN